{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:51:13Z","timestamp":1777053073975,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,28]]},"DOI":"10.7759\/cureus.28505","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T19:28:26Z","timestamp":1661714906000},"source":"Crossref","is-referenced-by-count":7,"title":["Role of Serotoninergic Antidepressants in the Development of Autism Spectrum Disorders: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Sheena","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumahitha","family":"Bichenapally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahe","family":"Khachatryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Muazzam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandani","family":"Hamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi Sai Deepak Reddy","family":"Velugoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godfrey","family":"Tabowei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greeshma N","family":"Gaddipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed  J","family":"Alzubaidee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raga Sruthi","family":"Dwarampudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.07.010","article-title":"Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder","volume":"140","author":"Garbarino VR","year":"2019","unstructured":"Garbarino VR, Gilman TL, Daws LC, Gould GG. Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol Res. 2019, 140:85-99. 10.1016\/j.phrs.2018.07.010","journal-title":"Pharmacol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13608","article-title":"Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study","volume":"84","author":"B\u00e9nard-Laribi\u00e8re A","year":"2018","unstructured":"B\u00e9nard-Laribi\u00e8re A, Pambrun E, Sutter-Dallay AL, et al.. Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study. Br J Clin Pharmacol. 2018, 84:1764-75. 10.1111\/bcp.13608","journal-title":"Br J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1039\/c8tx00102b","article-title":"Maternal SSRIs experience and risk of ASD in offspring: a review","volume":"7","author":"Fatima Z","year":"2018","unstructured":"Fatima Z, Zahra A, Ghouse M, Wang X, Yuan Z. Maternal SSRIs experience and risk of ASD in offspring: a review. Toxicol Res (Camb). 2018, 7:1020-8. 10.1039\/c8tx00102b","journal-title":"Toxicol Res (Camb)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.20614","article-title":"Association between maternal use of SSRI medications and autism in their children","volume":"317","author":"King BH","year":"2017","unstructured":"King BH. Association between maternal use of SSRI medications and autism in their children. JAMA. 2017, 317:1568-9. 10.1001\/jama.2016.20614","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2015.3356","article-title":"Antidepressant use during pregnancy and the risk of autism spectrum disorder in children","volume":"170","author":"Boukhris T","year":"2016","unstructured":"Boukhris T, Sheehy O, Mottron L, B\u00e9rard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016, 170:117-24. 10.1001\/jamapediatrics.2015.3356","journal-title":"JAMA Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2059","article-title":"Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study","volume":"346","author":"Rai D","year":"2013","unstructured":"Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013, 346:f2059. 10.1136\/bmj.f2059","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13004","article-title":"Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research","volume":"60","author":"Sujan AC","year":"2019","unstructured":"Sujan AC, \u00d6berg AS, Quinn PD, D'Onofrio BM. Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research. J Child Psychol Psychiatry. 2019, 60:356-76. 10.1111\/jcpp.13004","journal-title":"J Child Psychol Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.33552\/SJRR.2019.01.000509","article-title":"The adverse effects of antidepressant medication treatments on the offspring of women with perinatal depression","volume":"2","author":"Ali AM","unstructured":"Ali AM, Hassan AA, Hendawy AO. The adverse effects of antidepressant medication treatments on the offspring of women with perinatal depression. Sci J Research Rev. 1, 2:1-5. 10.33552\/SJRR.2019.01.000509","journal-title":"Sci J Research Rev"},{"key":"ref9","article-title":"Autism spectrum disorder (ASD): A current review of assessment, risk factors, and prevention","volume":"55","author":"Balaji G","year":"2018","unstructured":"Balaji G, Sinha SN. Autism spectrum disorder (ASD): A current review of assessment, risk factors, and prevention. Indian J Clin Biochem Biophys. 2018, 55:375-83.","journal-title":"Indian J Clin Biochem Biophys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp-rj.2018.130602","article-title":"Choosing and discussing SSRIs for depression in pregnancy: a basic guide for residents","volume":"13","author":"Gorun A","year":"2018","unstructured":"Gorun A. Choosing and discussing SSRIs for depression in pregnancy: a basic guide for residents. Am J  Psychiatry . 2018, 13:3-5. 10.1176\/appi.ajp-rj.2018.130602","journal-title":"Am J  Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717001301","article-title":"Autism risk following antidepressant medication during pregnancy","volume":"47","author":"Viktorin A","year":"2017","unstructured":"Viktorin A, Uher R, Reichenberg A, Levine SZ, Sandin S. Autism risk following antidepressant medication during pregnancy. Psychol Med. 2017, 47:2787-96. 10.1017\/S0033291717001301","journal-title":"Psychol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-017-3246-6","article-title":"Interactive effects of prenatal antidepressant exposure and likely gene disrupting mutations on the severity of autism spectrum disorder","volume":"47","author":"Ackerman S","year":"2017","unstructured":"Ackerman S, Schoenbrun S, Hudac C, Bernier R. Interactive effects of prenatal antidepressant exposure and likely gene disrupting mutations on the severity of autism spectrum disorder. J Autism Dev Disord. 2017, 47:3489-96. 10.1007\/s10803-017-3246-6","journal-title":"J Autism Dev Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.3415","article-title":"Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children","volume":"317","author":"Brown HK","year":"2017","unstructured":"Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA. 2017, 317:1544-52. 10.1001\/jama.2017.3415","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20040418","article-title":"Antidepressants, pregnancy, and autism: setting the record(s) straight","volume":"177","author":"Maloney SE","year":"2020","unstructured":"Maloney SE, Rogers CE, Constantino JN. Antidepressants, pregnancy, and autism: setting the record(s) straight. Am J Psychiatry. 2020, 177:479-81. 10.1176\/appi.ajp.2020.20040418","journal-title":"Am J Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17f11903","article-title":"Antidepressant exposure during pregnancy and risk of autism in the offspring, 1: meta-review of meta-analyses","volume":"78","author":"Andrade C","year":"2017","unstructured":"Andrade C. Antidepressant exposure during pregnancy and risk of autism in the offspring, 1: meta-review of meta-analyses. J Clin Psychiatry. 2017, 78:e1047-51. 10.4088\/JCP.17f11903","journal-title":"J Clin Psychiatry"},{"key":"ref16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71.","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0356","article-title":"Prenatal antidepressant exposure and child motor development: a meta-analysis","volume":"142","author":"Grove K","year":"2018","unstructured":"Grove K, Lewis AJ, Galbally M. Prenatal antidepressant exposure and child motor development: a meta-analysis. Pediatrics. 2018, 142:e20180356. 10.1542\/peds.2018-0356","journal-title":"Pediatrics"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-813323-1.00002-5","article-title":"Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder","author":"Daly E","year":"2019","unstructured":"Daly E, Tricklebank MD, Wichers R. Neurodevelopmental roles and the serotonin hypothesis of autism spectrum disorder.  The serotonin system. Academic press, 2019. 21June:23-44. 10.1016\/B978-0-12-813323-1.00002-5"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2018.06.025","article-title":"Maternal serotonin levels are associated with cognitive ability and core symptoms in autism spectrum disorder","volume":"57","author":"Montgomery AK","year":"2018","unstructured":"Montgomery AK, Shuffrey LC, Guter SJ, et al.. Maternal serotonin levels are associated with cognitive ability and core symptoms in autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2018, 57:867-75. 10.1016\/j.jaac.2018.06.025","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2016.07.016","article-title":"Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis","volume":"65","author":"Kobayashi T","year":"2016","unstructured":"Kobayashi T, Matsuyama T, Takeuchi M, Ito S. Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis. Reprod Toxicol. 2016, 65:170-8. 10.1016\/j.reprotox.2016.07.016","journal-title":"Reprod Toxicol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0207-7","article-title":"Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis","volume":"9","author":"Zhou XH","year":"2018","unstructured":"Zhou XH, Li YJ, Ou JJ, Li YM. Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis. Mol Autism. 2018, 9:21. 10.1186\/s13229-018-0207-7","journal-title":"Mol Autism"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2811","article-title":"Antidepressants during pregnancy and autism in offspring: population based cohort study","volume":"358","author":"Rai D","year":"2017","unstructured":"Rai D, Lee BK, Dalman C, Newschaffer C, Lewis G, Magnusson C. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ. 2017, 358:j2811. 10.1136\/bmj.j2811","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1724","article-title":"Neonatal and childhood outcomes in offspring of pregnant women using antidepressant medications: a critical review of current meta\u2010analyses","volume":"61","author":"Uguz F","year":"2021","unstructured":"Uguz F. Neonatal and childhood outcomes in offspring of pregnant women using antidepressant medications: a critical review of current meta\u2010analyses. J Clin Pharmacol. 2021, 61:146-58. 10.1002\/jcph.1724","journal-title":"J Clin Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0993-3","article-title":"Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations","volume":"16","author":"Morales DR","year":"2018","unstructured":"Morales DR, Slattery J, Evans S, Kurz X. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations. BMC Med. 2018, 16:6. 10.1186\/s12916-017-0993-3","journal-title":"BMC Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.0124","article-title":"Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis","volume":"171","author":"Mezzacappa A","year":"2017","unstructured":"Mezzacappa A, Lasica PA, Gianfagna F, et al.. Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis. JAMA Pediatr. 2017, 171:555-63. 10.1001\/jamapediatrics.2017.0124","journal-title":"JAMA Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S180618","article-title":"Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring","volume":"10","author":"Hagberg KW","year":"2018","unstructured":"Hagberg KW, Robijn AL, Jick S. Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol. 2018, 10:1599-612. 10.2147\/CLEP.S180618","journal-title":"Clin Epidemiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s40748-018-0096-y","article-title":"Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data","volume":"5","author":"Yamamoto-Sasaki M","year":"2019","unstructured":"Yamamoto-Sasaki M, Yoshida S, Takeuchi M, Tanaka-Mizuno S, Ogawa Y, Furukawa TA, Kawakami K. Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data. Matern Health Neonatol Perinatol. 2019, 5:1. 10.1186\/s40748-018-0096-y","journal-title":"Matern Health Neonatol Perinatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.3413","article-title":"Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring","volume":"317","author":"Sujan AC","year":"2017","unstructured":"Sujan AC, Rickert ME, \u00d6berg AS, et al.. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring. JAMA. 2017, 317:1553-62. 10.1001\/jama.2017.3413","journal-title":"JAMA"},{"key":"ref29","unstructured":"Prenatal exposure to SSRI antidepressants and the risk of autism spectrum disorder (ASD) in children. (2017). Accessed. July 8, 2022: https:\/\/ruor.uottawa.ca\/handle\/10393\/36984."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13382","article-title":"Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies","volume":"83","author":"Kaplan YC","year":"2017","unstructured":"Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K. Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies. Br J Clin Pharmacol. 2017, 83:2798-806. 10.1111\/bcp.13382","journal-title":"Br J Clin Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13030","article-title":"In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta-analysis","volume":"139","author":"Halvorsen A","year":"2019","unstructured":"Halvorsen A, Hesel B, \u00d8stergaard SD, Danielsen AA. In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2019, 139:493-507. 10.1111\/acps.13030","journal-title":"Acta Psychiatr Scand"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311X00026619","article-title":"Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review","volume":"36","author":"Araujo JS","year":"2020","unstructured":"Araujo JS, Delgado IF, Paumgartten FJ. Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review. Cad Saude Publica. 2020, 36:e00026619. 10.1590\/0102-311X00026619","journal-title":"Cad Saude Publica"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210303121059","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) during pregnancy and the risk for autism spectrum disorder (asd) and attention deficit hyperactivity disorder (adhd) in the offspring: a true effect or a bias? A systematic review & meta-analysis","volume":"19","author":"Leshem R","year":"2021","unstructured":"Leshem R, Bar-Oz B, Diav-Citrin O, Gbaly S, Soliman J, Renoux C, Matok I. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) during pregnancy and the risk for autism spectrum disorder (asd) and attention deficit hyperactivity disorder (adhd) in the offspring: a true effect or a bias? A systematic review & meta-analysis. Curr Neuropharmacol. 2021, 19:896-906. 10.2174\/1570159X19666210303121059","journal-title":"Curr Neuropharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.1076","article-title":"Variations in neurodevelopmental outcomes in children with prenatal SSRI antidepressant exposure","volume":"109","author":"Rotem-Kohavi N","year":"2017","unstructured":"Rotem-Kohavi N, Oberlander TF. Variations in neurodevelopmental outcomes in children with prenatal SSRI antidepressant exposure. Birth Defects Res. 2017, 109:909-23. 10.1002\/bdr2.1076","journal-title":"Birth Defects Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/108354-role-of-serotoninergic-antidepressants-in-the-development-of-autism-spectrum-disorders-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:31Z","timestamp":1707508111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/108354-role-of-serotoninergic-antidepressants-in-the-development-of-autism-spectrum-disorders-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,28]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.28505","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,28]]}}}